Detection of protein glycosylation

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201300047C
Awardee
Awarding agency
Obligated
$947,400

Award facts

Opportunity
  • N44CA3101451 Solicitation number
Contract value 100% obligated
$947,399.62 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
St. Louis, MO 63110, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 4 · Modified to deobligate all remaining funds and administratively close the contract -$22,370
Other Administrative Action 3 · Protein glycosylation $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $969,770

Quick answers

Who was awarded contract HHSN261201300047C?

HHSN261201300047C was awarded to Mediomics LLC by National Cancer Institute (National Institutes of Health) on September 13, 2013.

How much is contract HHSN261201300047C worth?

The government has obligated $947,400 on HHSN261201300047C.

Was contract HHSN261201300047C competed?

The extent of competition for HHSN261201300047C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login